These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3158611)

  • 1. Tissue distribution of ciprofloxacin following oral and intravenous administration.
    Dalhoff A; Eickenberg HU
    Infection; 1985; 13(2):78-81. PubMed ID: 3158611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue.
    Daschner FD; Westenfelder M; Dalhoff A
    Eur J Clin Microbiol; 1986 Apr; 5(2):212-3. PubMed ID: 2941285
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraperitoneal penetration of ciprofloxacin.
    Lockley MR; Waldron R; Wise R; Donovan IA
    Eur J Clin Microbiol; 1986 Apr; 5(2):209-10. PubMed ID: 2941284
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.
    Goormans E; Dalhoff A; Kazzaz B; Branolte J
    Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and multiple dose pharmacokinetics of ciprofloxacin.
    Ullmann U; Giebel W; Dalhoff A; Koeppe P
    Eur J Clin Microbiol; 1986 Apr; 5(2):193-6. PubMed ID: 2941279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
    Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D
    Eur J Clin Microbiol; 1986 Apr; 5(2):179-86. PubMed ID: 2941277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin pharmacokinetics in patients with cystic fibrosis.
    Bender SW; Dalhoff A; Shah PM; Strehl R; Posselt HG
    Infection; 1986; 14(1):17-21. PubMed ID: 2937737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
    Boerema JB; Dalhoff A; Debruyne FM
    Chemotherapy; 1985; 31(1):13-8. PubMed ID: 3156024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection.
    Peters HJ
    Eur J Clin Microbiol; 1986 Apr; 5(2):253-5. PubMed ID: 2941295
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection.
    Grabe M; Forsgren A; Björk T
    Eur J Clin Microbiol; 1986 Apr; 5(2):211-2. PubMed ID: 2424755
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.
    Ball AP; Fox C; Ball ME; Brown IR; Willis JV
    J Antimicrob Chemother; 1986 May; 17(5):629-35. PubMed ID: 2941402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Crump B; Wise R; Dent J
    Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.
    Goldfarb J; Wormser GP; Inchiosa MA; Guideri G; Diaz M; Gandhi R; Goltzman C; Mascia AV
    J Clin Pharmacol; 1986 Mar; 26(3):222-6. PubMed ID: 2937812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target site concentrations of ciprofloxacin after single intravenous and oral doses.
    Brunner M; Stabeta H; Möller JG; Schrolnberger C; Erovic B; Hollenstein U; Zeitlinger M; Eichler HG; Müller M
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.
    Clode AB; Davis JL; Salmon J; LaFevers H; Gilger BC
    Am J Vet Res; 2010 May; 71(5):564-9. PubMed ID: 20433383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin concentrations in tonsils following a single intravenous infusion.
    Falser N; Dalhoff A; Weuta H
    Infection; 1984; 12(5):355-7. PubMed ID: 6511090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin concentrations in bone and muscle after oral dosing.
    Fong IW; Ledbetter WH; Vandenbroucke AC; Simbul M; Rahm V
    Antimicrob Agents Chemother; 1986 Mar; 29(3):405-8. PubMed ID: 2940971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose ciprofloxacin dose ranging and kinetics.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Drusano GL
    Clin Pharmacol Ther; 1985 Jun; 37(6):633-7. PubMed ID: 3159530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration activities of ciprofloxacin into muscle, skin and fat following oral administration.
    Dalhoff A; Aigner KR; Eickenberg HU
    Chemioterapia; 1987 Jun; 6(2 Suppl):294-5. PubMed ID: 3509419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.